China In Vitro Diagnostic (IVD) Webinar for U.S. Exporters
Wednesday, December 4th
11am EST / 8am PST
Join the U.S. Commercial Service and a panel of experts to learn valuable insights on the China IVD market!
China’s IVD market was valued at $16.6 billion in 2023 and is projected to reach $21 billion by 2028.
Clinical immunity, driven by the chemiluminescence market, has been the largest segment in China’s IVD market in recent years. In 2023, the gradual recovery of routine hospital testing has led to an increased demand for biochemical testing. Additionally, the rise in microbial infection cases, due to the prevalence of respiratory diseases following the pandemic, has contributed to a resurgence in microbiological testing.
China’s IVD market shows growth potential across various segments, including molecular diagnostics, point-of-care testing, immunoassay, hematology, pathology, microbiology, and clinical biochemicals.
This free webinar will provide an overview of China’s IVD market, highlighting market opportunities, access requirements, IP considerations, and the latest regulatory updates.
|
